GGrantIndex
← Leaderboards

Andrew R Marks

Columbia University Health Sciences

$38,589,991
Attributed
$47,598,009
Total exposure
27
Grants
22
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$62,618,698 · 28

By mechanism

R01$32,866,748 · 14
P01$20,055,776 · 7
T32$6,543,704 · 2
RF1$2,310,158 · 1
R25$678,456 · 2
R03$147,856 · 1

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Phosphorylation

Research focus

PhosphorylationHeart FailureSignal TransductionRyanodine Receptor Calcium Release ChannelPreventArrhythmiaMouse ModelCalciumCyclic Amp-Dependent Protein KinasesLaboratoriesCardiacHeartRyr2MolecularBaseFunctional DisorderLinkRyr1Pharmaceutical PreparationsDesignCalcium ChannelComplexLeadPlay

Grant awards (134)

Exploring the Molecular Physiology of Atrial Fibrillation$772,293
R01 · FY2025 · HL
Deciphering Statin-Induced Muscle Symptoms: Mechanisms and Therapeutic Insights$654,388
R01 · FY2025 · HL · contact PI
Regulation of OXPHOS Assembly in Skeletal Muscles$428,615
R01 · FY2025 · GM · contact PI
Ryanodine receptor structure and function in heart failure$427,700
P01 · FY2025 · HL · contact PI
Training in Cardiovascular Sciences for Undergraduate Rising Stars (CURS)$123,984
R25 · FY2025 · HL · contact PI
Exploring the Molecular Physiology of Atrial Fibrillation$756,847
R01 · FY2024 · HL
Calcium and the Pathophysiology of Neurodegenerative Disorders$571,456
R01 · FY2024 · NS · contact PI
Regulation of OXPHOS Assembly in Skeletal Muscles$439,184
R01 · FY2024 · GM · contact PI
Ryanodine receptor structure and function in heart failure$419,146
P01 · FY2024 · HL · contact PI
Training in Cardiovascular Sciences for Under Represented Students$123,984
R25 · FY2024 · HL · contact PI
Exploring the Molecular Physiology of Atrial Fibrillation$772,293
R01 · FY2023 · HL
Training in Cardiovascular Translational Research$441,658
T32 · FY2023 · HL · contact PI
Ryanodine receptor structure and function in heart failure$427,700
P01 · FY2023 · HL · contact PI
Training in Cardiovascular Sciences for Under Represented Students$128,520
R25 · FY2023 · HL · contact PI
Exploring the Molecular Physiology of Atrial Fibrillation$767,599
R01 · FY2022 · HL
Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants$762,832
R01 · FY2022 · HL · contact PI
Training in Cardiovascular Translational Research$486,363
T32 · FY2022 · HL · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2022 · HL · contact PI
Calcium and the physiology of diabetes$405,000
R01 · FY2022 · DK · contact PI
Training in Cardiovascular Sciences for Under Represented Students$123,984
R25 · FY2022 · HL · contact PI
Summer Program for Under Represented Students (SPURS)$54,000
R25 · FY2022 · NS
Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants$770,600
R01 · FY2021 · HL · contact PI
Exploring the Molecular Physiology of Atrial Fibrillation$718,064
R01 · FY2021 · HL
Training in Cardiovascular Translational Research$605,154
T32 · FY2021 · HL · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2021 · HL · contact PI
Calcium and the physiology of diabetes$405,000
R01 · FY2021 · DK · contact PI
Training in Cardiovascular Sciences for Under Represented Students$123,984
R25 · FY2021 · HL · contact PI
Calcium and the Pathophysiology of Neurodegenerative Disorders$2,310,158
RF1 · FY2020 · NS · contact PI
Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants$762,832
R01 · FY2020 · HL · contact PI
Exploring the Molecular Physiology of Atrial Fibrillation$718,065
R01 · FY2020 · HL
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$600,621
R01 · FY2020 · CA
Training in Cardiovascular Translational Research$597,144
T32 · FY2020 · HL · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2020 · HL · contact PI
Calcium and the physiology of diabetes$405,000
R01 · FY2020 · DK · contact PI
Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants$89,490
R01 · FY2020 · HL · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$22,156
R01 · FY2020 · HL · contact PI
Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants$762,832
R01 · FY2019 · HL · contact PI
Exploring the Molecular Physiology of Atrial Fibrillation$718,064
R01 · FY2019 · HL
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$604,910
R01 · FY2019 · CA
Training in Cardiovascular Translational Research$577,895
T32 · FY2019 · HL · contact PI
Ryanodine Receptor Defects in Cardiomyopathy Caused by Lamin A/C Gene Mutations$452,970
R01 · FY2019 · HL · contact PI
Calcium and the physiology of diabetes$405,000
R01 · FY2019 · DK · contact PI
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$20,000
R01 · FY2019 · CA
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$15,365
R01 · FY2019 · CA
Exploring the Molecular Physiology of Atrial Fibrillation$733,064
R01 · FY2018 · HL
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$630,724
R01 · FY2018 · CA
Training in Cardiovascular Translational Research$441,466
T32 · FY2018 · HL · contact PI
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$52,355
R01 · FY2018 · CA
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$20,000
R01 · FY2018 · CA
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$637,172
R01 · FY2017 · CA
Training in Cardiovascular Translational Research$457,663
T32 · FY2017 · HL · contact PI
Training in Cardiovascular Translational Research$4,963
T32 · FY2017 · HL · contact PI
(PQ#9)Targeting leaky ryanodine receptor (RyR2) to treat and prevent chemotherapy-associated cognitive dysfunction in patients with breast cancer.$655,037
R01 · FY2016 · CA
Training in Cardiovascular Translational Research$467,161
T32 · FY2016 · HL · contact PI
Molecular Basis of Heart Failure$400,000
R01 · FY2016 · HL · contact PI
Training in Cardiovascular Translational Research$436,469
T32 · FY2015 · HL · contact PI
Molecular Basis of Heart Failure$394,000
R01 · FY2015 · HL · contact PI
Macromolecular Local Signaling Complexes$16,000
R13 · FY2015 · HL · contact PI
Molecular Basis of Heart Failure$392,000
R01 · FY2014 · HL · contact PI
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci$392,000
R01 · FY2014 · HL · contact PI
Intracellular calcium leak and muscle function$340,805
R01 · FY2014 · AR · contact PI
Training in Cardiovascular Translational Research$213,459
T32 · FY2014 · HL · contact PI
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci$380,800
R01 · FY2013 · HL · contact PI
Molecular Basis of Heart Failure$380,800
R01 · FY2013 · HL · contact PI
Intracellular calcium leak and muscle function$330,372
R01 · FY2013 · AR · contact PI
Molecular Basis of Heart Failure$400,000
R01 · FY2012 · HL · contact PI
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci$400,000
R01 · FY2012 · HL · contact PI
Intracellular calcium leak and muscle function$347,760
R01 · FY2012 · AR · contact PI
Molecular Basis of Sudden Cardiac Death$1,595,905
P01 · FY2011 · HL · contact PI
Molecular Basis of Heart Failure$402,500
R01 · FY2011 · HL · contact PI
Novel Therapeutic Approaches to Atrial Fibrillation Targeting Intracellular Calci$400,417
R01 · FY2011 · HL · contact PI
Multidisciplinary Training in Translational Cardiovascular Research$395,961
T32 · FY2011 · HL · contact PI
Intracellular calcium leak and muscle function$347,760
R01 · FY2011 · AR · contact PI
Intracellular Calcium Release Channels and Cardiac Arrhythmias$319,185
P01 · FY2011 · HL · contact PI
Administrative Core$319,180
P01 · FY2011 · HL · contact PI
Molecular Basis of Sudden Cardiac Death$1,597,599
P01 · FY2010 · HL · contact PI
Molecular Basis of Heart Failure$420,153
R01 · FY2010 · HL · contact PI
Multidisciplinary Training in Translational Cardiovascular Research$408,745
T32 · FY2010 · HL · contact PI
Intracellular calcium leak and muscle function$362,250
R01 · FY2010 · AR · contact PI
Intracellular Calcium Release Channels and Cardiac Arrhythmias$326,933
P01 · FY2010 · HL · contact PI
Administrative Core$326,930
P01 · FY2010 · HL · contact PI
Molecular Basis of Sudden Cardiac Death$37,054
P01 · FY2010 · HL · contact PI
Molecular Basis of Sudden Cardiac Death$1,570,588
P01 · FY2009 · HL · contact PI
Multidisciplinary Training in Translational Cardiovascular Research$406,205
T32 · FY2009 · HL · contact PI
Molecular Basis of Heart Failure$402,500
R01 · FY2009 · HL · contact PI
Cardiac and skeletal muscle calcium release channels$390,828
R01 · FY2009 · HL · contact PI
REGULATION OF RYANODINE RECEPTORS BY ALLOSTERIC MODULATION$390,519
P01 · FY2009 · HL · contact PI
Molecular Basis of Sudden Cardiac Death$37,746
P01 · FY2009 · HL · contact PI
Molecular Basis of Heart Failure$35,266
R01 · FY2009 · HL · contact PI
Molecular Basis of Sudden Cardiac Death$1,539,178
P01 · FY2008 · HL · contact PI
Multidisciplinary Training in Translational Cardiovascular Research$403,691
T32 · FY2008 · HL · contact PI
Molecular Basis of Heart Failure$402,500
R01 · FY2008 · HL · contact PI
Cardiac and skeletal muscle calcium release channels$390,828
R01 · FY2008 · HL · contact PI
REGULATION OF RYANODINE RECEPTORS BY ALLOSTERIC MODULATION$382,708
P01 · FY2008 · HL · contact PI
Molecular Basis of Sudden Cardiac Death$1,585,838
P01 · FY2007 · HL · contact PI
Intracellular Calcium Release Channels and Cardiac Arrhythmias$436,018
P01 · FY2007 · HL · contact PI
Regulation of cardiac ion channel function via allosteric modulators$424,830
R01 · FY2007 · HL · contact PI
Cardiac and skeletal muscle calcium release channels$390,828
R01 · FY2007 · HL · contact PI
REGULATION OF RYANODINE RECEPTORS BY ALLOSTERIC MODULATION$389,506
P01 · FY2007 · HL · contact PI
Multidisciplinary Training in Translational Cardiovascular Research$199,707
T32 · FY2007 · HL · contact PI
Intracellular Calcium and Sudden Cardiac Death$156,884
P01 · FY2007 · HL · contact PI
Cardiac and skeletal muscle calcium release channels$402,500
R01 · FY2006 · HL · contact PI
Regulation of cardiac ion channel function via allosteric modulators$402,500
R01 · FY2006 · HL · contact PI
Molecular Basis of Heart Failure$399,144
R01 · FY2006 · HL · contact PI
Regulation of cardiac ion channel function via allosteric modulators$13,283
R01 · FY2006 · HL · contact PI
Cardiac and skeletal muscle calcium release channels$12,075
R01 · FY2006 · HL · contact PI
Molecular Basis of Sudden Cardiac Death$1,476,863
P01 · FY2005 · HL
Cardiac and skeletal muscle calcium release channels$419,215
R01 · FY2005 · HL
Molecular Basis of Heart Failure$408,750
R01 · FY2005 · HL
Intracellular calcium release channels and cardiac arrhythmias$369,215
P01 · FY2005 · HL
Molecular Basis of Heart Failure$31,556
R01 · FY2005 · HL
Molecular Basis of Sudden Cardiac Death$1,441,500
P01 · FY2004 · HL
Molecular Basis of Heart Failure$423,923
R01 · FY2004 · HL
Cardiac and skeletal muscle calcium release channels$408,750
R01 · FY2004 · HL
Coupled gating between intracellular calcium release ch*$40,320
R03 · FY2004 · TW
Cardiac and skeletal muscle calcium release channels$37,835
R01 · FY2004 · HL
Molecular Basis of Heart Failure$33,356
R01 · FY2004 · HL
Molecular Basis of Sudden Cardiac Death$1,407,179
P01 · FY2003 · HL
Cardiac and skeletal muscle calcium release channels$408,750
R01 · FY2003 · HL
Molecular Basis of Heart Failure$408,750
R01 · FY2003 · HL
Coupled gating between intracellular calcium release ch*$40,320
R03 · FY2003 · TW
Molecular Basis of Sudden Cardiac Death$1,373,855
P01 · FY2002 · HL
Cardiac and skeletal muscle calcium release channels$408,750
R01 · FY2002 · HL
MOLECULAR BASIS OF HEART FAILURE$391,000
R01 · FY2002 · HL
Intracellular calcium release channels and cardiac arrhythmias$343,463
P01 · FY2002 · HL
Coupled gating between intracellular calcium release ch*$38,500
R03 · FY2002 · TW
Molecular Basis of Sudden Cardiac Death$1,357,384
P01 · FY2001 · HL
Cardiac and skeletal muscle calcium release channels$408,750
R01 · FY2001 · HL
MOLECULAR BASIS OF HEART FAILURE$391,000
R01 · FY2001 · HL
Intracellular calcium release channels and cardiac arrhythmias$0
P01 · FY2001 · HL
MOLECULAR BASIS OF HEART FAILURE$391,000
R01 · FY2000 · HL
CARDIAC AND SKELETAL MUSCLE CALCIUM RELEASE CHANNELS$357,249
R01 · FY2000 · HL
CALCIUM CHANNELS IN NON EXCITABLE CELLS$290,677
R01 · FY2000 · AI
REGULATION OF CALCIUM RELEASE CHANNELS$28,716
R03 · FY2000 · TW